Volume 9, Number 8—August 2003
Research
Community-Acquired Methicillin-Resistant Staphylococcus aureus Carrying Panton-Valentine Leukocidin Genes: Worldwide Emergence
François Vandenesch*, Timothy Naimi†, Mark C. Enright‡, Gerard Lina*, Graeme R. Nimmo§, Helen Heffernan¶, Nadia Liassine#, Michèle Bes*, Timothy Greenland**, Marie-Elisabeth Reverdy*, and Jerome Etienne*
Table 3
Origin and frequency of Staphylococcus aureus isolates according to their sequence typesa
| Sequence type | Present study | Data from the MLST Web site | ||||
|---|---|---|---|---|---|---|
| Country of origin of CA-MRSA |
n |
Country of origin of MSSA |
n |
Country of origin of MRSA |
n |
|
| 1 |
USA |
29 |
UK, Denmark, the Netherlands, Canada, |
20 |
0 |
|
| 8 |
USA |
3 |
UK, the Netherlands, Denmark, US, Canada |
46 |
Scotland, Ireland, Australia, U.S., UK, Germany, The Netherlands, France |
39 |
| 30 |
Oceania (Southwest Pacific clone) |
13 |
UK, Denmark, Germany |
83 |
UK, Spain, Germany,
Sweden |
8 |
| 59 |
USA |
1 |
UK |
4 |
U.S. |
1 |
| 80 |
France, Switzerland |
67 |
0 |
Greece |
1 |
|
| 93 | Australia (Queensland clone) | 4 | 0 | 0 | ||
aMLST, multi-locus sequence typing ; MRSA, methicillin resistant S. aureus; MSSA, methicillin-susceptible S. aureus; CA, community acquired.
Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.